Contribute Try STAT+ Today

WASHINGTON — President Donald Trump has tapped deputy White House chief of staff Jim Carroll to serve as the administration’s next drug czar.

Carroll’s position as head of the Office of National Drug Control Policy will make him the most public face of the administration’s efforts to fight the opioid epidemic — an effort critics say hasn’t gone nearly far enough.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Carroll may be very competent in his own field; but there are many professionals in medicine and public health with vast training and experience in this very complex arena. But true to form, Trump nominates somebody with none of that relevant background.
    “Only the best”, he promised, instead bringing us a deeper swamp than ever. It will take years to remedy the damages this “administration” is bringing our nation.

Comments are closed.